Clinical Trial Comparing Two Bladder Instillations for IC/BPS

PHASE3CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

January 25, 2019

Primary Completion Date

October 23, 2020

Study Completion Date

October 23, 2020

Conditions
Interstitial CystitisBladder Pain Syndrome
Interventions
DRUG

Bladder instillation WITH triamcinolone acetonide

Bladder instillation mixture of heparin (10,000 units), 2% viscous lidocaine (10 mL), 8.4% sodium bicarbonate (15 mL of 1 mEq/mL), 0.5% bupivacaine (10 mL of 5 mg/mL) plus triamcinolone acetonide (1 vial, 40 milligrams (mg)/1 milliliters (mL).

DRUG

Bladder instillation WITHOUT triamcinolone acetonide

Bladder instillation mixture of heparin (10,000 units), 2% viscous lidocaine (10 mL), 8.4% sodium bicarbonate (15 mL of 1 mEq/mL), and 0.5% bupivacaine (10 mL of 5 mg/mL).

Trial Locations (1)

40205

University of Louisville Urogynecology at Springs Medical Center, Louisville

All Listed Sponsors
lead

Olivia Cardenas-Trowers, M.D.

OTHER

NCT03463915 - Clinical Trial Comparing Two Bladder Instillations for IC/BPS | Biotech Hunter | Biotech Hunter